Abstract
The present review summarizes the existing literature data regarding the development of newer categories of antidiabetic agents, their mechanism of action and their clinical importance. In this paper, a review of the recent patents for the treatment of diabetes will be presented. In recent years significant achievements have been done, including the development of SGLT2 inhibitors, glucokinase activators as well as the role of free fatty acids and bile acid metabolism in the treatment of diabetes are reviewed.
Keywords: Bile acid synthesis, Low density lipoprotein cholesterol, sodium-coupled glucose transporters, free fatty acids, glucokinase activators, SGLT2 inhibitors, Dapagliflozin, Type 2 diabetes mellitus, Diet-induced obesity
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued)
Title: Challenges for the Treatment of Diabetes Mellitus
Volume: 5 Issue: 3
Author(s): Athanasia K. Papazafiropoulou, Marina S. Kardara and Stavros I. Pappas
Affiliation:
Keywords: Bile acid synthesis, Low density lipoprotein cholesterol, sodium-coupled glucose transporters, free fatty acids, glucokinase activators, SGLT2 inhibitors, Dapagliflozin, Type 2 diabetes mellitus, Diet-induced obesity
Abstract: The present review summarizes the existing literature data regarding the development of newer categories of antidiabetic agents, their mechanism of action and their clinical importance. In this paper, a review of the recent patents for the treatment of diabetes will be presented. In recent years significant achievements have been done, including the development of SGLT2 inhibitors, glucokinase activators as well as the role of free fatty acids and bile acid metabolism in the treatment of diabetes are reviewed.
Export Options
About this article
Cite this article as:
K. Papazafiropoulou Athanasia, S. Kardara Marina and I. Pappas Stavros, Challenges for the Treatment of Diabetes Mellitus, Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) 2011; 5 (3) . https://dx.doi.org/10.2174/187221411797265953
DOI https://dx.doi.org/10.2174/187221411797265953 |
Print ISSN 1872-2148 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3334 |
Related Articles
-
Oxidative Stress in Polycystic Ovary Syndrome
Current Pharmaceutical Design Andrographolide Reorganise Hyperglycaemia and Distorted Antioxidant Profile in Streptozotocin-Induced Diabetic Rats
Cardiovascular & Hematological Agents in Medicinal Chemistry Insulin Resistance and Alzheimers Disease Pathogenesis: Potential Mechanisms and Implications for Treatment
Current Alzheimer Research (Pro)renin Receptor: Pathological Role and Therapeutic Potential in Primary Hypertension
Current Hypertension Reviews Epidemiology and Natural History of Alcoholic Liver Disease
Reviews on Recent Clinical Trials The Heart in Sepsis: From Basic Mechanisms to Clinical Management
Current Vascular Pharmacology Ultrasound Features of Polycystic Ovaries and Syndrome X: A Pilot Study
Vascular Disease Prevention (Discontinued) Shoulder Manifestations of Diabetes Mellitus
Current Diabetes Reviews Antioxidants and its Properties as Affected by Extrusion Process: A Review
Recent Patents on Food, Nutrition & Agriculture The Role of Mitochondrial Dysfunction in Heart Failure and Potential Therapeutic Targets
Current Pharmaceutical Design Alterations in Plasma Triglyceride Concentrations Following Two Oral Meals with Different Fat Content in Patients with Type 2 Diabetes Mellitus
Current Vascular Pharmacology Hyperuricaemia and Non-Alcoholic Fatty Liver Disease (NAFLD): A Relationship with Implications for Vascular Risk?
Current Vascular Pharmacology Novel Strategies for Preventing Diabetes and Obesity Complications with Natural Polyphenols
Current Medicinal Chemistry Actinomycetes as a Paramount Source of Biologically Important Enzyme Inhibitors – “A Boon to Mankind”
Current Bioactive Compounds A Brief Review of Cardiovascular Diseases, Associated Risk Factors and Current Treatment Regimes
Current Pharmaceutical Design Combination of SGLT-2 Inhibitors and GLP-1 Receptor Agonists: Potential Benefits in Surrogate and Hard Endpoints
Current Pharmaceutical Design Non-transfusion Dependent Thalassemias: A Developing Country Perspective
Current Pediatric Reviews Patent Selections
Recent Patents on Inflammation & Allergy Drug Discovery Hypertensive Treatment and the Metabolic Syndrome
Current Hypertension Reviews Molecular Interaction Study of N1-p-fluorobenzyl-cymserine with TNF-α , p38 Kinase and JNK Kinase
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry